Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco A Zarbin

Showing results (11-20 of 151) with videos related to

Pageof 16
Sort By:
Archives of Ophthalmology (Chicago, Ill. : 1960)|April 14, 2004
Current concepts in the pathogenesis of age-related macular degenerationMarco A Zarbin
JAMA Ophthalmology|August 9, 2014
The First International Optogenetic Therapies for Vision Symposium: Translational Medicine in ProgressMarco A Zarbin
JAMA Ophthalmology|May 27, 2016
Challenges in Applying the Results of Clinical Trials to Clinical PracticeMarco A Zarbin
Asia-Pacific Journal of Ophthalmology (Philadelphia, Pa.)|June 25, 2015
The Nanotechnology RevolutionMarco A Zarbin
Asia-Pacific Journal of Ophthalmology (Philadelphia, Pa.)|February 7, 2018
Anti-VEGF Agents and the Risk of Arteriothrombotic EventsMarco A Zarbin
JAMA Ophthalmology|April 13, 2013
Accelerated in vitro degradation of optically clear low-β sheet silk films by enzyme-mediated pretreatmentMarco A Zarbin
JAMA Ophthalmology|February 16, 2013
Recombinant T-cell receptor ligands in the treatment of uveitisMarco A Zarbin
Translational Vision Science & Technology|August 21, 2015
ARVO Embraces Open AccessMarco A Zarbin
JAMA Ophthalmology|June 15, 2013
Apical scotomata, confusion, and diplopiaMarco A Zarbin
JAMA Ophthalmology|June 15, 2013
Personalized medicine: Bayesian inference as applied to the measurement of glaucomatous visual field lossMarco A Zarbin
Pageof 16

Showing results (11-20 of 151) with videos related to

Sort By:
Pageof 16
Archives of Ophthalmology (Chicago, Ill. : 1960)|April 14, 2004
Current concepts in the pathogenesis of age-related macular degenerationMarco A Zarbin
JAMA Ophthalmology|August 9, 2014
The First International Optogenetic Therapies for Vision Symposium: Translational Medicine in ProgressMarco A Zarbin
JAMA Ophthalmology|May 27, 2016
Challenges in Applying the Results of Clinical Trials to Clinical PracticeMarco A Zarbin
Asia-Pacific Journal of Ophthalmology (Philadelphia, Pa.)|June 25, 2015
The Nanotechnology RevolutionMarco A Zarbin
Asia-Pacific Journal of Ophthalmology (Philadelphia, Pa.)|February 7, 2018
Anti-VEGF Agents and the Risk of Arteriothrombotic EventsMarco A Zarbin
JAMA Ophthalmology|April 13, 2013
Accelerated in vitro degradation of optically clear low-β sheet silk films by enzyme-mediated pretreatmentMarco A Zarbin
JAMA Ophthalmology|February 16, 2013
Recombinant T-cell receptor ligands in the treatment of uveitisMarco A Zarbin
Translational Vision Science & Technology|August 21, 2015
ARVO Embraces Open AccessMarco A Zarbin
JAMA Ophthalmology|June 15, 2013
Apical scotomata, confusion, and diplopiaMarco A Zarbin
JAMA Ophthalmology|June 15, 2013
Personalized medicine: Bayesian inference as applied to the measurement of glaucomatous visual field lossMarco A Zarbin
Pageof 16